Literature DB >> 31833071

The Spectrum of Reactive Cholangiocytes in Primary Sclerosing Cholangitis.

Maria Eugenia Guicciardi1,2, Christy E Trussoni1,2, Nicholas F LaRusso1,2, Gregory J Gores1,2.   

Abstract

Cholangiocytes are the target of a group of chronic liver diseases termed the "cholangiopathies," in which cholangiocytes react to exogenous and endogenous insults, leading to disease initiation and progression. In primary sclerosing cholangitis (PSC), the focus of this review, the cholangiocyte response to genetic or environmental insults can lead to a heterogeneous response; that is, a subpopulation acquires a ductular reactive and proliferative phenotype, while another subpopulation undergoes senescence and growth arrest. Both ductular reactive cholangiocytes and senescent cholangiocytes can modify the periductal microenvironment through their ability to secrete various cytokines, chemokines, and growth factors, initiating and perpetuating inflammatory and profibrotic responses. This review discusses the similarities and differences, the interrelationships, and the potential pathogenic roles of these reactive proliferative and senescent cholangiocyte subpopulations in PSC.
© 2020 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2020        PMID: 31833071      PMCID: PMC7012677          DOI: 10.1002/hep.31067

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  43 in total

1.  Hepatic progenitor cell-mediated regeneration and fibrosis: chicken or egg?

Authors:  Andrew D Clouston; Julie R Jonsson; Elizabeth E Powell
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

2.  Targeting senescent cholangiocytes and activated fibroblasts with B-cell lymphoma-extra large inhibitors ameliorates fibrosis in multidrug resistance 2 gene knockout (Mdr2-/- ) mice.

Authors:  Anja Moncsek; Mohammed S Al-Suraih; Christy E Trussoni; Steven P O'Hara; Patrick L Splinter; Camille Zuber; Eleonora Patsenker; Piero V Valli; Christian D Fingas; Achim Weber; Yi Zhu; Tamar Tchkonia; James L Kirkland; Gregory J Gores; Beat Müllhaupt; Nicholas F LaRusso; Joachim C Mertens
Journal:  Hepatology       Date:  2017-11-29       Impact factor: 17.425

Review 3.  Emerging concepts in biliary repair and fibrosis.

Authors:  Luca Fabris; Carlo Spirli; Massimiliano Cadamuro; Romina Fiorotto; Mario Strazzabosco
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-05-19       Impact factor: 4.052

4.  Bone marrow injection stimulates hepatic ductular reactions in the absence of injury via macrophage-mediated TWEAK signaling.

Authors:  Thomas G Bird; Wei-Yu Lu; Luke Boulter; Sabrina Gordon-Keylock; Rachel A Ridgway; Michael J Williams; Jessica Taube; James A Thomas; Davina Wojtacha; Adriana Gambardella; Owen J Sansom; John P Iredale; Stuart J Forbes
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-01       Impact factor: 11.205

5.  Cholangiocyte senescence by way of N-ras activation is a characteristic of primary sclerosing cholangitis.

Authors:  James H Tabibian; Steven P O'Hara; Patrick L Splinter; Christy E Trussoni; Nicholas F LaRusso
Journal:  Hepatology       Date:  2014-04-25       Impact factor: 17.425

6.  Senolytic therapies for healthy longevity.

Authors:  Jan M van Deursen
Journal:  Science       Date:  2019-05-17       Impact factor: 47.728

7.  Peribiliary Gland Niche Participates in Biliary Tree Regeneration in Mouse and in Human Primary Sclerosing Cholangitis.

Authors:  Guido Carpino; Lorenzo Nevi; Diletta Overi; Vincenzo Cardinale; Stuart J Forbes; Domenico Alvaro; Eugenio Gaudio; Wei-Yu Lu; Sabina Di Matteo; Samira Safarikia; Pasquale Bartolomeo Berloco; Rosanna Venere; Paolo Onori; Antonio Franchitto
Journal:  Hepatology       Date:  2019-10-10       Impact factor: 17.425

Review 8.  Mitochondrial dysfunction and cell senescence: deciphering a complex relationship.

Authors:  James Chapman; Edward Fielder; João F Passos
Journal:  FEBS Lett       Date:  2019-06-27       Impact factor: 4.124

Review 9.  Cellular senescence and the senescent secretory phenotype: therapeutic opportunities.

Authors:  Tamara Tchkonia; Yi Zhu; Jan van Deursen; Judith Campisi; James L Kirkland
Journal:  J Clin Invest       Date:  2013-03-01       Impact factor: 14.808

10.  Cellular senescence mediates fibrotic pulmonary disease.

Authors:  Marissa J Schafer; Thomas A White; Koji Iijima; Andrew J Haak; Giovanni Ligresti; Elizabeth J Atkinson; Ann L Oberg; Jodie Birch; Hanna Salmonowicz; Yi Zhu; Daniel L Mazula; Robert W Brooks; Heike Fuhrmann-Stroissnigg; Tamar Pirtskhalava; Y S Prakash; Tamara Tchkonia; Paul D Robbins; Marie Christine Aubry; João F Passos; James L Kirkland; Daniel J Tschumperlin; Hirohito Kita; Nathan K LeBrasseur
Journal:  Nat Commun       Date:  2017-02-23       Impact factor: 14.919

View more
  19 in total

1.  Knockout of the Tachykinin Receptor 1 in the Mdr2-/- (Abcb4-/-) Mouse Model of Primary Sclerosing Cholangitis Reduces Biliary Damage and Liver Fibrosis.

Authors:  Ludovica Ceci; Heather Francis; Tianhao Zhou; Thao Giang; Zhihong Yang; Fanyin Meng; Nan Wu; Lindsey Kennedy; Konstantina Kyritsi; Vik Meadows; Chaodong Wu; Suthat Liangpunsakul; Antonio Franchitto; Amelia Sybenga; Burcin Ekser; Romina Mancinelli; Paolo Onori; Eugenio Gaudio; Shannon Glaser; Gianfranco Alpini
Journal:  Am J Pathol       Date:  2020-07-23       Impact factor: 4.307

2.  Targeted Apoptosis of Ductular Reactive Cells Reduces Hepatic Fibrosis in a Mouse Model of Cholestasis.

Authors:  Adiba I Azad; Anuradha Krishnan; Leia Troop; Ying Li; Tomohiro Katsumi; Kevin Pavelko; Enis Kostallari; Maria Eugenia Guicciardi; Gregory J Gores
Journal:  Hepatology       Date:  2020-09       Impact factor: 17.425

Review 3.  Cellular senescence in the cholangiopathies.

Authors:  Pamela S Bogert; Steven P O'Hara; Nicholas F LaRusso
Journal:  Curr Opin Gastroenterol       Date:  2022-03-01       Impact factor: 3.287

4.  Senescence markers in focal nodular hyperplasia of the liver: pathogenic considerations on the basis of immunohistochemical results.

Authors:  Helmut Denk; Daniela Pabst; Peter M Abuja; Robert Reihs; Brigitte Tessaro; Kurt Zatloukal; Carolin Lackner
Journal:  Mod Pathol       Date:  2021-10-13       Impact factor: 7.842

5.  Senescent cholangiocytes release extracellular vesicles that alter target cell phenotype via the epidermal growth factor receptor.

Authors:  Mohammed S Al Suraih; Christy E Trussoni; Patrick L Splinter; Nicholas F LaRusso; Steven P O'Hara
Journal:  Liver Int       Date:  2020-07-07       Impact factor: 5.828

Review 6.  Intrahepatic cholangiocarcinoma: Morpho-molecular pathology, tumor reactive microenvironment, and malignant progression.

Authors:  Alphonse E Sirica; Mario Strazzabosco; Massimiliano Cadamuro
Journal:  Adv Cancer Res       Date:  2020-12-09       Impact factor: 6.242

7.  Long non-coding RNA ACTA2-AS1 promotes ductular reaction by interacting with the p300/ELK1 complex.

Authors:  Amaia Navarro-Corcuera; Tejasav S Sehrawat; Nidhi Jalan-Sakrikar; Hunter R Gibbons; Nicholas E Pirius; Shalil Khanal; Feda H Hamdan; Sayed Obaidullah Aseem; Sheng Cao; Jesus M Banales; Ningling Kang; William A Faubion; Nicholas F LaRusso; Vijay H Shah; Robert C Huebert
Journal:  J Hepatol       Date:  2021-12-23       Impact factor: 25.083

8.  IL-17A/F enable cholangiocytes to restrict T cell-driven experimental cholangitis by upregulating PD-L1 expression.

Authors:  Stephanie Stein; Lara Henze; Tobias Poch; Antonella Carambia; Till Krech; Max Preti; Fenja Amrei Schuran; Maria Reich; Verena Keitel; Romina Fiorotto; Mario Strazzabosco; Lutz Fischer; Jun Li; Luisa Marie Müller; Jonas Wagner; Nicola Gagliani; Johannes Herkel; Dorothee Schwinge; Christoph Schramm
Journal:  J Hepatol       Date:  2020-11-13       Impact factor: 25.083

Review 9.  Fibrotic Events in the Progression of Cholestatic Liver Disease.

Authors:  Hanghang Wu; Chaobo Chen; Siham Ziani; Leonard J Nelson; Matías A Ávila; Yulia A Nevzorova; Francisco Javier Cubero
Journal:  Cells       Date:  2021-05-05       Impact factor: 6.600

10.  Cholangiocyte senescence in primary sclerosing cholangitis is associated with disease severity and prognosis.

Authors:  Nora Cazzagon; Samantha Sarcognato; Annarosa Floreani; Giorgia Corrà; Sara De Martin; Vincenza Guzzardo; Francesco Paolo Russo; Maria Guido
Journal:  JHEP Rep       Date:  2021-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.